How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks

How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks

Karen Andersen, biotechnology strategist for Morningstar Research Services, discusses what GLP-1 drugs’ demand means for the biopharma industry’s five-year outlook. And whether the weight-loss drugs pose a threat to snack food stocks.

Why GLP-1 Drugs Are in Demand

Competition Between Novo Nordisk and Eli Lilly

How Expanding the Conditions GLP-1 Drugs Treats Could Influence Insurance Coverage

Are Weight Loss Drugs a Threat to Snack Food Stocks?

Big Pharma’s Looming Patent Cliff

How Medicare Negotiations Impact the Pharmaceutical Industry

What is a Biologic Drug?

Upcoming Innovations in the Pharmaceutical Industry

Which BioPharma Drugs Do We Expect to Contract?

Big Pharma’s Five-Year Outlook

Biopharmaceutical Stock Picks

Read about topics from this episode.

2024 Biopharmaceutical Industry Landscape

Obesity Drugs: Can New Firms Take Market Share From Eli Lilly and Novo Nordisk?

Investment Opportunities in the Biopharma Industry

Obesity Drug Market: The Next Wave of GLP-1 Competition

What to watch from Morningstar.

Is the Fed’s Plan to Avoid a Recession Working?

Don't Overlook These Crucial Parts of Your Retirement Plan

Boating Season Is Over, but Don't Overlook These Recreational Vehicle Stocks

5 Ways to Improve America’s Retirement Savings

Read what our team is writing:

Karen Andersen

Ivanna Hampton

Follow us on social media.

Facebook: https://www.facebook.com/MorningstarInc/

X: https://x.com/MorningstarInc

Instagram: https://www.instagram.com/morningstar...

LinkedIn: https://www.linkedin.com/company/5161/


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(203)

Dividend Investing: How to Find the Right Balance Between Income and Growth

Dividend Investing: How to Find the Right Balance Between Income and Growth

There's just something about dividends. The popular investing strategy attracts retirees and other investors who need regular cash payouts, as well as those who like the tangible return dividends repr...

26 Jun 15min

Are Mutual Funds Becoming Obsolete?

Are Mutual Funds Becoming Obsolete?

Bryan Armour, Morningstar’s director of ETF and passive strategies research for North America, and Dan Sotiroff, Morningstar’s associate director of US passive strategies research, explain why ETFs an...

19 Jun 19min

Brace Your Portfolio for Mega-IPOs

Brace Your Portfolio for Mega-IPOs

2026 is the year of the mega-IPO. SpaceX, Anthropic, and OpenAI are working their way through the pipeline as anticipation builds for their blockbuster debuts. Elon Musk’s conglomerate is leading the ...

12 Jun 13min

The Portfolio That Has Been Beating the Classic 60/40, and Why It Matters for You

The Portfolio That Has Been Beating the Classic 60/40, and Why It Matters for You

Don't underestimate the benefits of portfolio diversification. A well-diversified portfolio can ride waves of market volatility, and new Morningstar research found that's what happened in 2025. When u...

5 Jun 13min

The Best Opportunities for Fund Investors Today

The Best Opportunities for Fund Investors Today

Morningstar stamps what it thinks about a fund’s future with this Medalist Rating. You’ve probably seen a star with the word Gold, Silver, or Bronze next to a fund you were researching on Morningstar....

29 Mai 11min

Will Vacation Inflation Affect Your Summer Travel? Here’s What to Know

Will Vacation Inflation Affect Your Summer Travel? Here’s What to Know

Macroeconomic conditions are squeezing US airlines and travelers just in time for the summer travel season.  Higher fuel costs due to the conflict in the Middle East are pushing up ticket prices. The ...

22 Mai 12min

Bond ETF Flows Just Flipped. Here's What It Means for You

Bond ETF Flows Just Flipped. Here's What It Means for You

ltrashort bond funds are experiencing highs and lows this year.    They racked up a record $24 billion monthly inflow in March. But their fortunes reversed in April. Investors yanked out $1.6 billion....

15 Mai 15min

How Big Tech's Bond Spree and Rising US Debt Are Creating Risks and Opportunities

How Big Tech's Bond Spree and Rising US Debt Are Creating Risks and Opportunities

Is a global debt emergency on the horizon?   Big Tech’s bond-issuing spree is helping to pay for its massive artificial intelligence buildout. And it’s not expected to slow down this year.  Meanwhile,...

8 Mai 16min

Populært innen Business og økonomi

stopp-verden
lydartikler-fra-aftenposten
dine-penger-pengeradet
rss-penger-polser-og-politikk
e24-podden
rss-borsmorgen-okonominyhetene
rss-skravla-gar
aftenbladet-intervjuer
pengepodden-2
finansredaksjonen
rss-pa-konto
livet-pa-veien-med-jan-erik-larssen
utbytte
tid-er-penger-en-podcast-med-peter-warren
morgenkaffen-med-finansavisen
okonomiamatorene
liberal-halvtime
pengesnakk
lederpodden
rss-politisk-preik